Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
- PMID: 23344543
- DOI: 10.1038/nrc3449
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC) is a highly lethal cancer, with increasing worldwide incidence, that is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infections. There are few effective treatments partly because the cell- and molecular-based mechanisms that contribute to the pathogenesis of this tumour type are poorly understood. This Review outlines pathogenic mechanisms that seem to be common to both viruses and which suggest innovative approaches to the prevention and treatment of HCC.
Similar articles
-
Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2016-23. doi: 10.1158/1055-9965.EPI-13-0397. Epub 2013 Aug 27. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23983238 Free PMC article.
-
Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma.J Med Virol. 2014 Feb;86(2):217-23. doi: 10.1002/jmv.23837. Epub 2013 Nov 6. J Med Virol. 2014. PMID: 24338810
-
Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinoma.Hum Pathol. 2006 Mar;37(3):332-8. doi: 10.1016/j.humpath.2005.11.007. Hum Pathol. 2006. PMID: 16613328
-
Oncogenic viruses and hepatocellular carcinoma.Clin Liver Dis. 2015 May;19(2):341-60. doi: 10.1016/j.cld.2015.01.006. Epub 2015 Mar 7. Clin Liver Dis. 2015. PMID: 25921667 Review.
-
Role of hepatitis viruses in multistep hepatocarcinogenesis.Dig Liver Dis. 2001 Jan-Feb;33(1):2-6. doi: 10.1016/s1590-8658(01)80126-2. Dig Liver Dis. 2001. PMID: 11303970 Review. No abstract available.
Cited by
-
The Impact of Sorafenib in Combination with Transarterial Chemoembolization on the Outcomes of Intermediate-Stage Hepatocellular Carcinoma.Asian Pac J Cancer Prev. 2021 Apr 1;22(4):1217-1224. doi: 10.31557/APJCP.2021.22.4.1217. Asian Pac J Cancer Prev. 2021. PMID: 33906315 Free PMC article.
-
MicroRNA‑1271‑5p alleviates the malignant development of hepatitis B virus‑mediated liver cancer via binding to AQP5.Mol Med Rep. 2021 May;23(5):386. doi: 10.3892/mmr.2021.12025. Epub 2021 Mar 24. Mol Med Rep. 2021. PMID: 33760167 Free PMC article.
-
Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice.Neoplasia. 2021 May;23(5):529-538. doi: 10.1016/j.neo.2021.04.004. Epub 2021 May 1. Neoplasia. 2021. PMID: 33945993 Free PMC article.
-
PRKAA/AMPK restricts HBV replication through promotion of autophagic degradation.Autophagy. 2016 Sep;12(9):1507-20. doi: 10.1080/15548627.2016.1191857. Epub 2016 Jun 15. Autophagy. 2016. PMID: 27305174 Free PMC article.
-
CircRNAs in hepatocellular carcinoma: characteristic, functions and clinical significance.Int J Med Sci. 2022 Nov 14;19(14):2033-2043. doi: 10.7150/ijms.74713. eCollection 2022. Int J Med Sci. 2022. PMID: 36483595 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical